期刊文献+

荷瘤大鼠射频消融治疗前、后白细胞介素-10表达水平的变化及其意义 被引量:2

Changes of IL-IO expression level in rats with Walker-256 tumor treated by radiofrequency ablation
原文传递
导出
摘要 目的探讨射频消融(RFA)治疗肝肿瘤大鼠后,其外周血、肝脏局部组织、脾脏组织内白细胞介素-10(IL—10)水平的变化及其意义。方法取30只Sprague-Dawley大鼠,制作肝肿瘤模型,随机分为RFA后1周组、RFA后2周组和对照组,每组10只。前2组分别于RFA处理后1周及2周处死,对照组不做RFA处理即处死。取射频灶周边(对照组取肿瘤周边)0.5cm范围内肝、脾组织及外周血,采用Ficoll密度梯度离心法分离出单个核细胞,应用流式细胞术检测IL-10表达水平。结果对照组大鼠肿瘤周边肝组织IL-10水平为(89.47±3.70),RFA后1周组为(81.62±10.19),RFA后2周组为(84.20±9.96),RFA后1周组与对照组比较差异有统计学意义;对照组大鼠脾脏组织IL-10水平为(96.32±0.89),RFA后1周组为(92.70±2.27),RFA后2周组为(96.34±0.97),RFA后1周组与对照组比较差异有统计学意义;对照组大鼠外周血IL-10水平为(95.92±2.31),RFA后1周组为(89.71±5.44),RFA后2周组为(87.67±11.11),RFA后1周组与对照组比较差异有统计学意义。结论RFA通过对肿瘤组织的原位灭活,在一定程度上解除肿瘤组织所释放的IL-10对荷瘤宿主的免疫抑制状态,削弱IL-10对机体抗肿瘤免疫应答,包括对机体及肿瘤局部树突状细胞分化成熟的抑制作用。 Objective To observe the change of IL-10 expression level in local liver and spleen tissues of rats with liver tumor treated by radiofrequency ablation (RFA). Methods The experimental liver tumor model was established in 30 Sprague-Dawley rats by implantation of tumor particles. The model rats were then randomly divided equally into three groups: a lw after RFA group, a 2w after RFA group and a control group. The rats in the former two groups were treated with RFA once for 4 minutes, while those in the control group were not. The peripheral blood, spleen and liver tissues around the tumor of the rats in the control group, group 1 w after RFA and group 2w after RFA were sampled, respectively, before and at the time-points of 1 w and 2w after RFA. The mononuclear cells of peripheral blood,spleen and liver tissue were separated by Ficoll density gradient centrifugation. The expression level of IL-10 in peripheral blood, spleen and liver tissue were analyzed with flow cytometry. Results The expression level of IL-10 in local area around tumor of was 89.47 ± 3.7, 81.62 ± 10.19 and 84.2 ± 9.96, respectively, in the control group, group lw after RFA and group 2w after RFA. The difference between group lw after RFA and control group was significant. The expression level of IL-10 in spleen was 96.32 ±0.89, 92.7 ± 2.26 and 96.34 ±0.97, respectively, in the control group, group 1 w after RFA and group 2w after RFA. The difference between group 1 w after RFA and control group was significant. The expression level of IL-10 in peripheral blood was 95.92 ± 2.31 , 89.71 ± 5.44 and 87.67 ± 11. 11, respectively, in the control group, group lw after RFA and group 2w after RFA. The difference between group lw after RFA and control group was significant. Conclusion RFA can destroy the tumor tissues in situ and relieve immune suppression caused by IL-10 secreted from tumor tissue, decrease inhibitory action of these factors on antitumor immunity response to a certain extent. RFA can also improve differentiation and matura- tion of DC in local area of tumor and promote ability of antigen-presentation of the body.
出处 《中华物理医学与康复杂志》 CAS CSCD 北大核心 2008年第1期22-26,共5页 Chinese Journal of Physical Medicine and Rehabilitation
基金 北京市科委重大项目培育专项(20005190040431)
关键词 射频消融 大鼠 肝肿瘤 白细胞介素-10 抗原提呈 Radiofrequency ablation Rat Liver tumor lnterleukin-10 Antigen-presentation
  • 相关文献

参考文献15

  • 1陈敏华,严昆,杨薇,高文,戴莹,王艳滨,张晖,霍苓,邢宝才,黄信孚.343例肝恶性肿瘤射频消融疗效及并发症[J].北京大学学报(医学版),2005,37(3):292-296. 被引量:64
  • 2王艳滨,陈敏华,严昆,张晖,霍苓.原发性肝癌射频治疗后局部免疫功能的变化及其临床意义[J].中国微创外科杂志,2006,6(10):803-806. 被引量:15
  • 3戴维德,范智慧,陈敏华,河福金,李洪民,刘静贤.正常大鼠肝脏射频消融前后外周血树突状细胞的变化及意义[J].中国介入影像与治疗学,2006,3(2):137-140. 被引量:4
  • 4Zou GM, Tam YK. Cytokines in the generation and maturation of dendritic cells : recent advances. Eur Cytokine N etw, 2002,13,186-199.
  • 5Yang AS, Lattime EC. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses. Cancer Res,2003,63:2150-2157.
  • 6Weber JC, Navarra G, Jiao LR, et al. New technique for liver resection using heat coagulative necrosis. Ann Surg,2002 ,236 :560-563.
  • 7罗葆明,王军华,潘景升,马健鸿,文艳玲,杨海云,戴晓宁,王捷,陈亚进.射频消融治疗肝癌对免疫功能的影响[J].中国临床医学影像杂志,2002,13(6):411-413. 被引量:19
  • 8Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol,2000 ,18 :767-812.
  • 9Gabrilovich DI, Corak J, Ciernik IF, et al. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res, 1997,3:483-490.
  • 10Gabrilovich D, Ciernik F, Carbone DP, et al. Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumorbearing hosts. Cell Immunol, 1996,170 : 101-110.

二级参考文献25

  • 1谭敏,王吉甫.大肠癌患者癌周组织免疫细胞的分布及其意义[J].癌症,1996,15(4):287-289. 被引量:3
  • 2Li G H,J Surg Oncol,1989年,41卷,5页
  • 3夏穗生,实用外科杂志,1992年,12卷,6期,507页
  • 4杨永康,实用外科杂志,1992年,12卷,10期,535页
  • 5Livraghi T, Meloni F, Goldberg SN, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesion.Radiology, 2000, 214: 761-768.
  • 6Bilchik AJ, Rose DM, Allegra DP, et al. Radiofrequency ablation: a minimally invasive technique with multiple applications.Cancer J Sci Am, 1999, 5: 356-361.
  • 7Sheu JL,Sung JL,Huang GT,et al. Intratumor injection of absolute ethanol under ultrasound guidance for treatment of small hepatocellular carcinoma.Hepatogastroenterology,1987,34:255-261
  • 8Livraghi T,Bolondi L,Lazzaroni S,et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis:a study on 207 patients. Cancer,1991,69:925-929
  • 9Vilana R,Bruix J,Bru C,et al. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma Hepatology,1992,16:353-357
  • 10Minami Y,Kono T,Miyazaki T,et al.The IL-2 receptor compel:its structure,function and target genes.Ann Rev Immunol,1993,11:245-268

共引文献109

同被引文献21

  • 1陈敏华,严昆,杨薇,高文,戴莹,王艳滨,张晖,霍苓,邢宝才,黄信孚.343例肝恶性肿瘤射频消融疗效及并发症[J].北京大学学报(医学版),2005,37(3):292-296. 被引量:64
  • 2王艳滨,吴后男,严昆,陈敏华,柯杨.肝细胞癌射频治疗前后淋巴细胞亚群及T细胞功能的变化[J].中国介入影像与治疗学,2006,3(2):115-121. 被引量:16
  • 3王艳滨,陈敏华,严昆,张晖,霍苓.原发性肝癌射频治疗后局部免疫功能的变化及其临床意义[J].中国微创外科杂志,2006,6(10):803-806. 被引量:15
  • 4Dauer M,Obermaier B,Herren J,et al.Mature dendritic cells derived from human monocytcs within 48 hours:a novel strategy for dendritic cell differentiation from blood precursors.J Immunol,2003,70:4069-4076.
  • 5O'Beirne jp,Harrison PM.The role of the immune system in the control of hepatocellular carcinoma.Eur J Gastroenterol Hepatol,2004,16:1257-1260.
  • 6Schueller G,Kettenbaeh J,Sedivy R,et al.Heat shock protein expression induced by perreutaneous radiofrequency ablation of hepatocellular carcinoma in vivo.Int J Oncol,2004,24:609-613.
  • 7Gillams AR.The USe of radiofrequeney in cancer.Br J Cancer,2005,92:1825-1829.
  • 8Moll H.Antigen delivery by dendritic cells.Int J Med Microbiol,2004,294:337-344.
  • 9Yang AS,Lattime EC.Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.Cancer Res,2003,63:2150-2157.
  • 10Garrigan K,Moroni-Rawsen P,MeMurray C,et al.Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors.Blood,1996,88:3508-3512.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部